Administration of second dose of SARS-CoV-2 recombinant spike protein antigen vaccine
Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)
procedure
Supplier: international · SCTID 1162646009
Also known as (13)
- Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen
- Second dose of 2019 novel coronavirus recombinant spike protein antigen immunisation
- Second dose of 2019 novel coronavirus recombinant spike protein antigen immunization
- Second dose of 2019 novel coronavirus recombinant spike protein antigen vaccination
- Second dose of 2019-nCoV recombinant spike protein antigen immunisation
- Second dose of 2019-nCoV recombinant spike protein antigen immunization
- Second dose of 2019-nCoV recombinant spike protein antigen vaccination
- Second dose of COVID-19 recombinant spike protein antigen immunisation
- Second dose of COVID-19 recombinant spike protein antigen immunization
- Second dose of COVID-19 recombinant spike protein antigen vaccination
- Second dose of SARS-CoV-2 recombinant spike protein antigen immunization
- Second dose of SARS-CoV-2 recombinant spike protein antigen vaccination
- Second dose of severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccination